Skip to main content
Home / CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Volume 7, Number 3
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 7, Number 3, 2008

Articles

Editorial [ Proteases and Phospholipases in CNS Disorders Guest Editor: Swapan K. Ray ]
pp. 225-226(2)
Author: Ray, Swapan K.

Favourites:
ADD

Therapeutic Strategy of Erythropoietin in Neurological Disorders
pp. 227-234(8)
Authors: Liu, Xiang-Bao; Wang, Jiang-An; Yu, Shan P.; Keogh, Christine L.; Wei, Ling

Favourites:
ADD

Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy
pp. 235-242(8)
Authors: Wang, Xiaoying; Rosell, Anna; Lo, Eng H.

Favourites:
ADD

Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies
pp. 243-253(11)
Authors: Adibhatla, Rao M.; Hatcher, James F.

Favourites:
ADD

Role of Secretory Phospholipase A2 in CNS Inflammation: Implications in Traumatic Spinal Cord Injury
pp. 254-269(16)
Authors: Titsworth, W. L.; Liu, Nai-Kui; Xu, Xiao-Ming

Favourites:
ADD

New Insights into the Roles of Endolysosomal Cathepsins in the Pathogenesis of Alzheimer's Disease: Cathepsin Inhibitors as Potential Therapeutics
pp. 270-277(8)
Authors: Haque, Azizul; Banik, Naren L.; Ray, Swapan K.

Favourites:
ADD

Beta-Secretase: Structure, Function, and Evolution
pp. 278-294(17)
Authors: Venugopal, Chitra; Demos, Christina M.; Jagannatha Rao, K. S.; Pappolla, Miguel A.; Sambamurti, Kumar

Favourites:
ADD

Neuroprotection in Glaucoma Using Calpain-1 Inhibitors: Regional Differences in Calpain-1 Activity in the Trabecular Meshwork, Optic Nerve and Implications for Therapeutics
pp. 295-304(10)
Authors: Govindarajan, Bharathi; Laird, James; Sherman, Ronald; Salomon, Robert G.; Bhattacharya, Sanjoy K.

Favourites:
ADD

Calpain as a Potential Therapeutic Target in Parkinson's Disease
pp. 305-312(8)
Authors: Samantaray, Supriti; Ray, Swapan K.; Banik, Naren L.

Favourites:
ADD

Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis
pp. 313-320(8)
Authors: Das, Arabinda; Guyton, M. K.; Butler, Jonathan T.; Ray, Swapan K.; Banik, Naren L.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content